September 14, 2026

FDA broadens APDS treatment options

An 8-patient study evaluated safety and pharmacokinetics in the younger pediatric population.

MDSpire News

September 09, 2026

Top 10 evidence-based essentials in pediatrics

A structured framework of guidelines, trials, therapies, and clinical tools used in pediatric practice.

MDSpire News

September 08, 2026

JIA risk may be linked to pregnancy factors

Investigators followed 78,901 offspring using pregnancy and national registry data through 2023.

MDSpire News

September 03, 2026

AI poised to reshape care

“This is really a unique time in our careers to see such a large change in technology."

MDSpire News

August 31, 2026

Do antihistamines help atopic dermatitis?

First-generation H1 antihistamines likely increase cognitive impairment, with cognitive effects differing among second-generation antihistamines.

MDSpire News

August 28, 2026

FDA approves XFG-adapted COVID-19 vaccine

The 2026 to 2027 formulation aligns with FDA guidance on the preferred composition for COVID-19 vaccines beginning this fall.

MDSpire News

August 25, 2026

FDA approves first therapy for warm autoimmune hemolytic anemia

The phase 2/3 ENERGY trial evaluated durable hemoglobin response with nipocalimab vs placebo in adults with warm autoimmune hemolytic anemia.

MDSpire News

August 04, 2026

An Overlooked Cause of Pediatric Anaphylaxis

Inhaling cumin during meal preparation triggered the first reported case of pediatric cumin-induced anaphylaxis, raising awareness of spice allergy.

MDSpire News

July 22, 2026

FDA Expands Pediatric Allergy Nasal Spray Use

A phase 3 randomized, double-blind, placebo-controlled trial in pediatric patients demonstrated improved nasal symptoms compared with placebo.

MDSpire News

July 17, 2026

FDA Grants Traditional Approval to Iptacopan in Primary IgAN

Novartis reported less annual eGFR decline with iptacopan than placebo over 2 years in the phase 3 APPLAUSE-IgAN trial.

MDSpire News